Jump to main content.

National Advisory Council for Environmental Policy and Technology (NACEPT)
Endocrine Disruptor Methods Validation Subcommittee (EDMVS)
First Plenary Meeting - October 30-31, 2001

Washington Dulles Airport Hilton
Grand Ballroom III
13869 Park Center Road
Herndon, VA 20171

Meeting Objectives

  • Present overview of the Environmental Protection Agency's (EPA) Endocrine Disruptor Program.
  • Provide background information on test protocol validation and approaches.
  • Develop clear understanding of the EDMVS scope, purpose, and operating procedures.
  • Determine next steps.

    Tuesday, October 30, 2001

    9:00 - 9:15 Welcome and Opening Comments
    Dr. Vanessa Vu, Chair, Director, Office of Science Coordination and Policy, (OSCP), EPA
    Dr. William Benson, Vice-Chair, Director, Gulf Ecology Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, (ORD), EPA

    9:15 - 9:45 Introductions and Agenda Review
    Paul De Morgan, Facilitator, RESOLVE

    9:45 - 10:00 Orientation to the Federal Advisory Committee Act and Ethics
    Peter Redmond, NACEPT Designated Federal Official (DFO), Office of Cooperative Environmental Management, (OCEM), EPA

    10:00 - 10:15 Overview of NACEPT
    Peter Redmond, NACEPT DFO, OCEM, EPA

    10:15 - 10:30 Break

    10:30 - 11:15 Overview of EPA's Regulatory Program for Endocrine Disruptors
    Gary Timm, OSCP, EPA

    11:15 - 12:00 Overview of EPA's Research Program for Endocrine Disruptors
    Dr. Elaine Francis, ORD, EPA

    12:00 - 1:00 Lunch

    1:00 - 1:30 Overview of the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) Test Protocol Validation Process
    Dr. Dave Hattan, Director, Division of Health, Food and Drug Administration

    1:30 - 2:15 Endocrine Disruptor Screening Program's (EDSP) Approaches to Test Protocol Validation and Process: Relationships Between ICCVAM, Organization for Economic Co-operation and Development (OECD), EPA, and EDMVS Gary Timm, OSCP, EPA

    2:15 - 3:00 EDSP's Test Protocol Validation Program: Status and Timeline Jim Kariya, OSCP, EPA

    3:00 - 3:15 Break

    3:15 - 4:30 Illustration of OECD Test Protocol Validation Process: the Uterotrophic Assay Dr. James W. Owens, Procter and Gamble

    4:30 - 5:15 Public Comment Members of the public will be given an opportunity to comment on any aspect of the EDMVS work. The amount of time given to each individual will depend on the number of people wishing to provide comment.

    5:15 - 5:30 Setting the Stage for Day Two

    Wednesday, October 31, 2001

    9:00 - 9:45 Overview of the Mission Statement
    Jane Smith, EDMVS DFO, OSCP, EPA

    9:45 - 10:45 EDMVS Operating Procedures Paul De Morgan, Facilitator, RESOLVE

    10:45 - 11:00 Break

    11:00 - 12:15 Looking Forward and Planning Next Steps

    12:15 - 12:30 Summary of Meeting and Closing Comments

    12:30 Adjourn

  • Local Navigation

    Jump to main content.